|Title||AI in medicine: Where are we now and where are we going?|
|Publication Type||Journal Article|
|Year of Publication||2022|
|Authors||MMH Shandhi, and JP Dunn|
|Journal||Cell Rep Med|
Advancements in AI enable personalizing healthcare, for example by investigating disease origins at the genetic or molecular level, understanding intraindividual drug effects, and fusing multi-modal personal physiological, behavioral, laboratory, and clinical data to uncover new aspects of pathophysiology. Future efforts should address equity, fairness, explainability, and generalizability of AI models.
|Short Title||Cell Rep Med|